4
Changes in Ownership
Zai Lab Ltd Filed Acc 0000905148-25-001753
Chairperson & CEO sold 96,389 shares at an average $28.34 ($2,731,507)
- Chairperson & CEO acquired 96,389 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Du Ying Chairperson & CEO | 2025-05-13 | Option exercise 10b5-1 | +50,000 | $0.60 | $30,000 | 529,851 | D |
| Du Ying Chairperson & CEO | 2025-05-13 | Sale 10b5-1 | −47,780 | $28.56 | $1,364,506 | 482,071 | D |
| Du Ying Chairperson & CEO | 2025-05-13 | Sale 10b5-1 | −2,220 | $28.89 | $64,144 | 479,851 | D |
| Du Ying Chairperson & CEO | 2025-05-14 | Option exercise 10b5-1 | +46,389 | $0.60 | $27,833 | 526,240 | D |
| Du Ying Chairperson & CEO | 2025-05-14 | Sale 10b5-1 | −46,006 | $28.08 | $1,291,816 | 480,234 | D |
| Du Ying Chairperson & CEO | 2025-05-14 | Sale 10b5-1 | −383 | $28.83 | $11,041 | 479,851 | D |
| Derivatives | |||||||
| Du Ying Chairperson & CEO | 2025-05-13 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −50,000 | 242,776 | D | ||
| Du Ying Chairperson & CEO | 2025-05-14 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −46,389 | 196,387 | D | ||
| Open-market sales · 96,389 sh · avg $28.34 · $2,731,507 | |||||||
Loading xslF345X05/form4.xml…